Precision Medicine in Early Oncology Trials: Biomarkers as Strategic Drivers
Pharmaceutical Technology
Biomarkers are revolutionizing oncology drug development, driving modern precision medicine approaches, targeted clinical trial recruitment strategies, and critical decision-making.
pharminent
April 10, 2026 (Last updated: April 10, 2026)
Pharmaceutical Technology
Biomarkers are revolutionizing oncology drug development, driving modern precision medicine approaches, targeted clinical trial recruitment strategies, and critical decision-making.
